CaMK4 promotes abortion-related Th17 cell imbalance by activating AKT/mTOR signaling pathway
CaMK4 promotes abortion-related Th17 cell imbalance by activating AKT/mTOR signaling pathway
复制标题
CaMK4通过激活AKT/mTOR信号通路促进流产相关Th17细胞失衡
DOI:
10.1111/aji.13315
复制
发表时间:
2020
影响因子:
3.6
通讯作者:
Yang Jing
中科院分区:
文献类型:
--
作者:
Chang Shuo;Yin Tailang;He Fan;Ding Jinli;Shang Ye;Yang Jing
ProblemThe balance of the immune microenvironment along the maternal‐fetal interface is closely related to pregnancy outcomes, with excessive inflammatory reactions leading to the occurrence of pathological pregnancy outcomes such as abortion. CaMK4 has been reported to play a significant role in autoimmune diseases through the regulation of Th17 cells. However, whether CaMK4 is associated with spontaneous abortion or the immune microenvironment along the maternal‐fetal interface remains unclear.Methods of studyIn this study, we constructed normal pregnancy and LPS‐induced abortion models in mice, and a CaMK4 inhibitor called KN‐93 was administered to investigate the changes in and mechanisms of the immune response. The expression of CaMK4 was evaluated in the uteroplacental complex and spleen. Furthermore, the infiltration and function of Th17 cells were estimated in peripheral tissues and the uteroplacental complex.ResultsThe expression of CaMK4 in the uteroplacental complex and spleen was significantly higher in the LPS‐treated group than in the normal pregnancy group. KN‐93, the CaMK4 inhibitor, reversed fetal resorption and excessive inflammation. In detail, KN‐93 led to reduced infiltration of Th17 cells into peripheral tissues and the uteroplacental complex, and the functions of Th17 cells were inhibited. In addition, CaMK4 promoted the AKT/mTOR signaling pathway, which is one of the mechanisms that regulate the immune microenvironment.ConclusionCaMK4 is a critical regulator that promotes the expansion of Th17 cells and enhances their functions through the AKT/mTOR signaling pathway. The inhibition of CaMK4 can reverse the immune imbalance along the maternal‐fetal interface and improve pregnancy outcomes.